Mead Johnson Nutrition Updates China Statement

  Mead Johnson Nutrition Updates China Statement

Business Wire

GLENVIEW, Ill. -- July 10, 2013

Mead Johnson Nutrition Company (NYSE: MJN) announced today that Mead Johnson
China continues to fully cooperate with the recent antitrust review of resale
prices which was initiated by the Bureau of Price Supervision and
Anti-Monopoly of China’s National Development and Reform Commission (NDRC).
Mead Johnson has also launched a self-review to ensure compliance with the
antitrust laws of China.

For the sake of the healthy development of the industry, and to reinforce the
trust and support of Chinese consumers, the company will optimize its
marketing and sales strategy and adjust current pricing and promotional plans.
As a result of this adjustment, Mead Johnson China will reduce the ex-factory
price of its main products by 7%-15% as of July 16, 2013. In addition, Mead
Johnson will launch new promotional campaigns through various channels to
further benefit consumers.

Mead Johnson Nutrition strives to provide safe and high-quality products at
good value to all consumers and continues to attach great importance to China.
Correspondingly, the company is committed to fully supporting and cooperating
with the relevant authorities, as well as promoting the healthy development of
the industry.

Mead Johnson Nutrition intends to update its earnings guidance for 2013 when
the company reports second quarter earnings on July 25, 2013. At this early
point, the company is looking at potential offsets throughout its global
operations.

Forward-Looking Statements

Certain statements in this news release are forward-looking as defined in the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements may be identified by the fact they use words such as “should,”
“expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,”
“intend,” “plan,” “believe” and other words and terms of similar meaning and
expression. Such statements are likely to relate to, among other things, a
discussion of goals, plans and projections regarding financial position,
results of operations, cash flows, market position, product development,
product approvals, sales efforts, expenses, capital expenditures, performance
or results of current and anticipated products and the outcome of
contingencies such as legal proceedings and financial results. Forward-looking
statements can also be identified by the fact that they do not relate strictly
to historical or current facts. Such forward-looking statements are based on
current expectations that involve inherent risks, uncertainties and
assumptions that may cause actual results to differ materially from
expectations as of the date of this news release. These risks include, but are
not limited to: (1) the ability to sustain brand strength, particularly the
Enfa family of brands; (2) the effect on the company’s reputation of real or
perceived quality issues; (3) the effect of regulatory restrictions related to
the company's products; (4) the adverse effect of commodity costs; (5)
increased competition from branded, private label, store and economy-branded
products; (6) the effect of an economic downturn on consumers’ purchasing
behavior and customers’ ability to pay for product; (7) inventory reductions
by customers; (8) the adverse effect of changes in foreign currency exchange
rates; (9) the effect of changes in economic, political and social conditions
in the markets where we operate; (10) changing consumer preferences; (11) the
possibility of changes in the WIC program, or participation in WIC; (12)
legislative, regulatory or judicial action that may adversely affect the
company’s ability to advertise its products or maintain product margins; and
(13) the ability to develop and market new, innovative products. For
additional information regarding these and other factors, see the company’s
filings with the United States Securities and Exchange Commission (the “SEC”),
including its most recent Annual Report on Form 10-K, which filings are
available upon request from the SEC or at www.meadjohnson.com. The company
cautions readers not to place undue reliance on any forward-looking
statements, which speak only as of the date made. The company undertakes no
obligation to publicly update any forward-looking statement, whether as a
result of new information, future events or otherwise.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures,
markets and distributes more than 70 products in over 50 countries worldwide.
The company’s mission is to nourish the world’s children for the best start in
life.

The Mead Johnson name has been associated with science-based pediatric
nutrition products for over 100 years. The company’s “Enfa” family of brands,
including Enfamil® infant formula, is the world’s leading brand franchise in
pediatric nutrition. For more information, visit meadjohnson.com.

Contact:

Mead Johnson Nutrition Company
Investors: Kathy MacDonald, (847) 832-2182, kathy.macdonald@mjn.com
Media: Christopher Perille, (847) 832-2178, chris.perille@mjn.com